| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $508K | — | +1924.9% |
| Cost of Revenue | $290K | — | +329.5% |
| Gross Profit | $218K | — | +614.9% |
| R&D Expense | $84K | — | — |
| SG&A Expense | $1.1M | — | +60.4% |
| Operating Income | -$1.3M | — | -53.3% |
| Pre-tax Income | -$1.1M | — | -40.1% |
| Income Tax | -$33K | — | +65.7% |
| Net Income | -$1.4M | — | -3.9% |
| EPS (Basic) | -$0.02 | — | +0.0% |
| EPS (Diluted) | -$0.02 | — | +0.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $36.7M | +8.6% | — |
| Short-term Investments | $3.2M | +41.9% | — |
| Accounts Receivable | $166K | -44.6% | — |
| Current Assets | $48.3M | +6.9% | — |
| Total Assets | $49.7M | +6.6% | — |
| Current Liabilities | $2.0M | +12.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$803K | — | -0.4% |
| Capital Expenditures | $11K | — | — |
| Investing Cash Flow | -$137K | — | +85.4% |
| Financing Cash Flow | $3.8M | — | +4.7% |
| Free Cash Flow | -$815K | — | — |
| Total Liabilities | $2.7M | +5.2% | — |
| Stockholders' Equity | $47.0M | +6.7% | +51.8% |